共病抑郁与慢性肢体威胁性缺血患者死亡率和截肢风险的关联
本回顾性研究纳入2007年1月1日至2018年12月31日单中心诊断的2987例慢性肢体威胁性缺血(CLTI)患者,分析共病抑郁与主要截肢及全因死亡的关系。结果显示共病抑郁与主要截肢风险升高相关,未服用抗抑郁药者全因死亡风险升高,而服用抗抑郁药者未见明显升高。
要点
- CLTI患者中诊断后6个月内共病抑郁者占7.1%(212例)。
- 共病抑郁与主要截肢风险升高相关(aOR 1.68,95%CI 1.19-2.37,P<.01)。
- 未服抗抑郁药者共病抑郁与全因死亡风险升高相关(aOR 2.64,95%CI 1.31-5.32,P=.03)。
核心结论
- CLTI患者共病抑郁与主要下肢截肢预后较差相关,未服用抗抑郁药者全因死亡预后较差,而服用抗抑郁药者全因死亡比值比改善。
研究设计与样本
- 回顾性研究,纳入2007年1月1日至2018年12月31日单中心诊断的2987例成人(≥18岁)CLTI患者。
主要发现
- 共病抑郁(CLTI诊断后6个月内)占7.1%(212例)。
- 多变量分析中,共病抑郁与主要截肢风险升高相关(aOR 1.68,95%CI 1.19-2.37,P<.01)。
- 未服用抗抑郁药者中,共病抑郁与全因死亡风险升高相关(aOR 2.64,95%CI 1.31-5.32,P=.03)。
- 服用抗抑郁药者中,共病抑郁与全因死亡风险无显著关联(aOR 1.06,95%CI 0.72-1.55,P=.99)。
- 共病抑郁对死亡率的影响因是否服用抗抑郁药而异(P=.02)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: There is increasing evidence that depression is a risk factor for worse outcomes in patients with peripheral artery disease. The association of depression in patients with chronic limb-threatening ischemia (CLTI) is not well described, nor is the impact of medical treatment for depression in this patient population. The objective of this study was to investigate the prevalence of depression in patients with CLTI, its association on major amputation and all-cause mortality, and whether medical antidepressant treatment is associated with improvement in these outcomes in patients with depression. METHODS: A retrospective review of all adult patients (≥18 years old) diagnosed with CLTI from January 1, 2007, to December 31, 2018, at a single academic medical center was performed. Collected data included patient demographics, comorbidities, and diagnosis of depression within 6 months of initial CLTI diagnosis. We also collected data on use of antidepressant medications. Outcomes evaluated were need for major lower extremity amputation and all-cause mortality. Multivariable logistic regression models estimated the adjusted effects of comorbid depression and antidepressant medication use on major amputation and all-cause mortality. Kaplan-Meier survival curves illustrated the probabilities of survival and limb salvage over time, stratified by diagnosis of comorbid depression. Multivariable Cox proportional hazards models estimated the adjusted effects of comorbid depression on time to major amputation and all-cause mortality, and the adjusted effect of antidepressant treatment on time to all-cause mortality. RESULTS: A total of 2987 patients with CLTI were identified. Mean age was 68.6 years (standard deviation, 12.9 years); 56.5% were male, and 43.5% were female. Comorbid depression within 6 months of CLTI diagnosis was present in 7.1% of the cohort (212 patients). In multivariable analysis, comorbid depression was associated with a 68% increase in the odds of major amputation (adjusted odds ratio [aOR], 1.68; 95% confidence interval [CI], 1.19-2.37; P < .01), a 164% increase in the odds of all-cause mortality among patients not taking antidepressants (aOR, 2.64; 95% CI, 1.31-5.32; P = .03), and only a 6% increase in the odds of all-cause mortality among patients taking antidepressants (aOR, 1.06; 95% CI, 0.72-1.55; P = .99). The effect of comorbid depression on mortality varied significantly by whether or not the patient was taking an antidepressant medication (P = .02). CONCLUSIONS: Comorbid depression in the patient population with CLTI is associated with a worse prognosis for major lower extremity amputation overall, and a worse prognosis for all-cause mortality among patients not taking an antidepressant. Furthermore, antidepressant treatment in the presence of comorbid depression in this patient population is associated with an improvement in the odds of all-cause mortality, illustrating the potential importance of medical management of depression.
引用
- Zielke T, Korepta L, Wesolowski M, et al. The association of comorbid depression with mortality and amputation risk in patients with chronic limb-threatening ischemia. J Vasc Surg. 2023. PMID: 37704093. doi:10.1016/j.jvs.2023.09.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。